- Home
- UNCY vs NAII Comparison
UNCY vs NAII Comparison
Compare UNCY & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- NAII
- Stock Information
- Founded
- UNCY 2016
- NAII 1980
- Country
- UNCY United States
- NAII United States
- Employees
- UNCY N/A
- NAII N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- NAII Medicinal Chemicals and Botanical Products
- Sector
- UNCY Health Care
- NAII Health Care
- Exchange
- UNCY Nasdaq
- NAII Nasdaq
- Market Cap
- UNCY 31.9M
- NAII 28.0M
- IPO Year
- UNCY 2021
- NAII 1987
- Fundamental
- Price
- UNCY $0.46
- NAII $4.53
- Analyst Decision
- UNCY Strong Buy
- NAII
- Analyst Count
- UNCY 4
- NAII 0
- Target Price
- UNCY $5.50
- NAII N/A
- AVG Volume (30 Days)
- UNCY 1.9M
- NAII 7.7K
- Earning Date
- UNCY 11-13-2024
- NAII 11-13-2024
- Dividend Yield
- UNCY N/A
- NAII N/A
- EPS Growth
- UNCY N/A
- NAII N/A
- EPS
- UNCY N/A
- NAII N/A
- Revenue
- UNCY N/A
- NAII $112,977,000.00
- Revenue This Year
- UNCY N/A
- NAII N/A
- Revenue Next Year
- UNCY N/A
- NAII N/A
- P/E Ratio
- UNCY N/A
- NAII N/A
- Revenue Growth
- UNCY N/A
- NAII N/A
- 52 Week Low
- UNCY $0.20
- NAII $4.13
- 52 Week High
- UNCY $1.82
- NAII $7.37
- Technical
- Relative Strength Index (RSI)
- UNCY 48.64
- NAII 45.33
- Support Level
- UNCY $0.41
- NAII $4.33
- Resistance Level
- UNCY $0.55
- NAII $4.81
- Average True Range (ATR)
- UNCY 0.06
- NAII 0.20
- MACD
- UNCY -0.01
- NAII 0.04
- Stochastic Oscillator
- UNCY 23.47
- NAII 43.40
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.